Effects of Indralin on Immunohematological Parameters and DNA Damage in Irradiated ICR (CD-1) Outbred Mice


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Abstract—Intragastric administration of radioprotector indralin (B-190 drug) to outbred SPF ICR (CD-1) mice 15 minutes before X-ray irradiation at doses of 6 Gy (LD-10/30), 6.5 Gy, and 7 Gy (LD-100/30) increases the 30-day survival of the animals and positively affects the state of the central organs of immunity and hematopoiesis, as well as the number of peripheral blood leukocytes. In addition, a positive effect on the behavioral reactions of the irradiated animals and striated muscles strength was noted. In addition to these secondary features of the indralin positive effect, a significant reduction of radiation-induced DNA damage in spleenocytes was observed using flow cytometry analysis of phosphorylated histone Н2АХ (γН2АХ) (1 h and eight days after X-ray irradiation) and DNA-comet assay (eight days after X-ray irradiation). The abovementioned methods are recommended for experiments investigating the influence of radioprotective drugs on DNA damage induction and repair in the irradiated organism, as well as for initial searching of potential radioprotectors and assessment of their effectiveness level in clinical practice and experiments.

作者简介

A. Bushmanov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
俄罗斯联邦, Moscow

A. Osipov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: a1931192@mail.ru
俄罗斯联邦, Moscow; Moscow

M. Ignatov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
俄罗斯联邦, Moscow

M. Vorontsova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
俄罗斯联邦, Moscow

T. Karaulova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
俄罗斯联邦, Moscow

A. Gordeev

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
俄罗斯联邦, Moscow

E. Yashkina

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
俄罗斯联邦, Moscow

O. Nikitenko

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Federal State Budgetary Institution of Science “Russian Federation State Scientific Center—Institute of Biomedical Problems,” Russian Academy of Sciences

Email: a1931192@mail.ru
俄罗斯联邦, Moscow; Moscow

T. Bychkova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Federal State Budgetary Institution of Science “Russian Federation State Scientific Center—Institute of Biomedical Problems,” Russian Academy of Sciences

Email: a1931192@mail.ru
俄罗斯联邦, Moscow; Moscow

N. Stavrakova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
俄罗斯联邦, Moscow

I. Andrianova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
俄罗斯联邦, Moscow

T. Blokhina

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: a1931192@mail.ru
俄罗斯联邦, Moscow; Moscow

N. Vorobyeva

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: a1931192@mail.ru
俄罗斯联邦, Moscow; Moscow

A. Ivanov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Federal State Budgetary Institution of Science “Russian Federation State Scientific Center—Institute of Biomedical Problems,” Russian Academy of Sciences; Joint Institute for Nuclear Research

编辑信件的主要联系方式.
Email: a1931192@mail.ru
俄罗斯联邦, Moscow; Moscow; Dubna

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2019